Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (opens in new window).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
APO-ARIPIPRAZOLE APOTEX INC Actual shortage 2MG New Report 2026-03-05 279893
APO-ARIPIPRAZOLE APOTEX INC Actual shortage 10MG New Report 2026-03-05 279890
APO-HYDROMORPHONE APOTEX INC Actual shortage 8MG New Report 2026-03-05 279887
APO-ARIPIPRAZOLE APOTEX INC Actual shortage 5MG New Report 2026-03-05 279884
APO-CEPHALEX APOTEX INC Actual shortage 500MG Updated Report 2026-03-05 279881
APO-PERINDOPRIL APOTEX INC Actual shortage 2MG Updated Report 2026-03-05 279878
APO-SAXAGLIPTIN APOTEX INC Actual shortage 2.5MG Updated Report 2026-03-05 279875
APO-BRIVARACETAM APOTEX INC Actual shortage 50MG New Report 2026-03-05 279872
MIRVALA 28 APOTEX INC Actual shortage 0.1500MG 0.0300MG New Report 2026-03-05 279869
APO-CLONAZEPAM APOTEX INC Actual shortage 2MG Updated Report 2026-03-05 279864

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ) ELI LILLY CANADA INC To be discontinued 70UNIT 30UNIT Updated Report 2026-03-05 257310
HUMULIN N ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2026-03-05 257307
HUMULIN R ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2026-03-05 257304
PROCYTOX TAB 25MG BAXTER CORPORATION To be discontinued 25MG Updated Report 2026-03-05 265250
KOMBOGLYZE ASTRAZENECA CANADA INC To be discontinued 850MG 2.5MG Updated Report 2026-03-03 277208
Get it on Google Play Download on the App Store